Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2010-09-17 | Roeland Nusse, Ph.D. (4) 2,100 178,100 180,200 |
| 2011-09-16 | Roeland Nusse, Ph.D. Age: 61 Role: Director Committees: Scientific Subcommittee Compensation: $105,200 Excerpt: "Dr. Nusse, Ph.D. has served on the Company’s Board since May 2010..." and "2011 Director Compensation: Roeland Nusse, Ph.D., $105,200 total compensation." |
| 2012-09-14 | Roeland Nusse, Ph.D. has served on the Company 27s Board since May 2010. Dr. Nusse earned a bachelor 27s degree in biology from the University of Amsterdam and a doctorate in molecular biology from the Netherlands Cancer Institute in 1980. He did his postdoctoral fellowship at the University of California, San Francisco. Dr. Nusse has served as Chairman of the Department of Developmental Biology at Stanford University since 2007. Dr. Nusse has been a professor or associate professor in the Department of Developmental Biology at Stanford University and an investigator at the Howard Hughes Medical Institute since 1990. He has also been the chair of the Department of Developmental Biology at Stanford since 2007. Dr. Nusse was previously at the Netherlands Cancer Institute (Amsterdam, The Netherlands) as a staff scientist and ultimately head of the Department of Molecular Biology. Dr. Nusse was elected to the United States National Academy of Sciences in April 2010. Dr. Nusse was previously named a member of the European Molecular Biology Organization in 1988, a member of the Royal Dutch Academy of Sciences in 1997 and a member of the American Academy of Arts and Sciences in 2001. Among other attributes, skills and qualifications, the Board believes Dr. Nusse is qualified to serve as a Director of the Company because his scientific research and academic background provide valuable strategic insight, including insight into the Company 27s customers and markets. |
| 2013-09-20 | Roeland Nusse, Ph.D. has served on the Company 27s Board since May 2010. Dr. Nusse earned a bachelor 27s degree in biology from the University of Amsterdam and a doctorate in molecular biology from the Netherlands Cancer Institute in 1980. He did his postdoctoral fellowship at the University of California, San Francisco. Dr. Nusse has served as Chairman of the Department of Developmental Biology at Stanford University since 2007. Dr. Nusse has been a professor or associate professor in the Department of Developmental Biology at Stanford University and an investigator at the Howard Hughes Medical Institute since 1990. He has also been the chair of the Department of Developmental Biology at Stanford since 2007. Dr. Nusse was previously at the Netherlands Cancer Institute (Amsterdam, The Netherlands) as a staff scientist and ultimately head of the Department of Molecular Biology. Dr. Nusse was elected to the United States National Academy of Sciences in April 2010. Dr. Nusse was previously named a member of the European Molecular Biology Organization in 1988, a member of the Royal Dutch Academy of Sciences in 1997 and a member of the American Academy of Arts and Sciences in 2001. Among other attributes, skills and qualifications, the Board believes Dr. Nusse is qualified to serve as a Director of the Company because his scientific research and academic background provide valuable strategic insight, including insight into the Company 27s customers and markets. |
| 2014-09-19 | Roeland Nusse, Ph.D. has served on the Companys Board since May 2010. ... Roeland Nusse, Ph.D. $205,640 total compensation. |
| 2015-09-18 | Roeland Nusse, Ph.D., age 65, has served on the Company’s Board since May 2010. ... Dr. Nusse has served as Chairman of the Department of Developmental Biology at Stanford University since 2007. ... The Board believes Dr. Nusse is qualified to serve as a Director of the Company because his scientific research and academic background provide valuable strategic insight, including insight into the Company’s customers and markets. |
| 2016-09-13 | Roeland Nusse, Ph.D., age 66, has served on the Company’s Board since May 2010. ... The Board currently has three standing Committees: the Audit Committee, the Executive Compensation Committee and the Nominations and Governance Committee. ... The membership of each standing committee during FY 2016 ... Roeland Nusse, Ph.D.: Nominations and Governance. ... Directors who are not employees of the Company were compensated for FY 2016 as follows: Roeland Nusse, Ph.D. total $241,312. |
| 2017-09-12 | Dr. Nusse has been a professor at Stanford University... Director Compensation for FY 2017: Roeland Nusse total $247,486. |
| 2018-09-11 | Dr. Nusse is professor at Stanford... Board believes Dr. Nusse is qualified... Member of Audit Committee and Chair of Science and Technology Committee. Director Compensation Table shows total $258,385. |
| 2019-09-09 | Roeland Nusse, Ph.D. Age: 68 Independent Director Since: 2010 Dr. Nusse brings valuable experience to the Board from his longstanding career as a researcher and department chair at Stanford University, including strategic leadership and scientific and industry knowledge. This experience allows him to provide the Board with insight into the Company's products, customers, and markets. Dr. Nusse also has a deep understanding of and contacts with the international life science research community. Director Compensation for FY 2019 Roeland Nusse, Ph.D. Total: $267,427 |
| 2020-09-15 | Roeland Nusse, Ph.D. Age: 70 Independent Director Since: 2010 Chair of Science & Technology Committee Member of Nominations & Governance Committee Director Compensation for FY 2020: $288,759 |
| 2024-09-12 | Roeland Nusse, Ph.D. Age: 74 Director since: 2010 INDEPENDENT Committees: Science & Technology (chair) ...Dr. Nusse has been a professor or associate professor in the Department of Developmental Biology at Stanford University. ...Compensation Paid to the Non-Employee Directors Roeland Nusse, Ph.D. Fees Earned or Paid in Cash: $90,000 Stock Awards: $99,954 Option Awards: $100,010 All Other Compensation: $498 Total: $290,462 |
Data sourced from SEC filings. Last updated: 2026-02-03